Multiple Sclerosis Room

In this room you can find updates and expert discussions about MS.

Improving support for people living with neurological and mental health conditions

Mental health and behavioural conditions, Neurological conditions, Neurology, Psychiatry, Multiple Sclerosis Room

Improving support for people living with neurological and mental health conditions

Jul 24, 2020

A presentation of urinary incontinence

CPD, Neurological conditions, Neurology, Multiple Sclerosis Room

A presentation of urinary incontinence

Jul 24, 2020

Member contribution

Expert Insights, Multiple Sclerosis Room

MS clinics: view from the frontline

Thoughts and local perspective on applying the latest ABN guidance on DMTs use in MS

Jul 10, 2020

Neurology – Journal Spy

Journal Spy, Neurological conditions, Neurology, Multiple Sclerosis Room

Cognitive impairment in benign multiple sclerosis: a multiparametric structural and functional MRI study.

Jul 03, 2020

VIDEO: McArdle Sign - a specific sign of multiple sclerosis

Neurological conditions, Neurology, Multiple Sclerosis Room

VIDEO: McArdle Sign - a specific sign of multiple sclerosis

Jun 29, 2020

Siponimodis not recommended for secondary progressive multiple sclerosis

Regulatory Alerts, Neurological conditions, Neurology, Multiple Sclerosis Room

Siponimodis not recommended for secondary progressive multiple sclerosis

Jun 25, 2020

ABN guidance summary: using DMTs in MS during the recovery phase of the COVID-19 pandemic

Neurological conditions, Neurology, Multiple Sclerosis Room

ABN guidance summary: using DMTs in MS during the recovery phase of the COVID-19 pandemic

Jun 19, 2020

Multiple Sclerosis: Raising the bar

Open Access Content, Neurological conditions, Neurology, Multiple Sclerosis Room

Multiple Sclerosis: Raising the bar

Jun 18, 2020

Multiple sclerosis

Clinical review

Neurological conditions, Multiple Sclerosis Room

Multiple sclerosis

Jun 16, 2020

Neurology – Journal Spy

Journal Spy, Neurological conditions, Neurology, Multiple Sclerosis Room

BOLD signal within and around white matter lesions distinguishes multiple sclerosis and non-specific white matter disease: a three-dimensional approach.

May 29, 2020

Neurology – Journal Spy

Journal Spy, Neurological conditions, Neurology, Multiple Sclerosis Room

Neurofilaments in progressive multiple sclerosis: a systematic review.

May 24, 2020

Update of COVID-19 and MS – Morbidity and mortality figures

Neurological conditions, Neurology, Multiple Sclerosis Room

Update of COVID-19 and MS – Morbidity and mortality figures

Neurology Academy

May 13, 2020

May 13, 2020

Multiple Sclerosis Room

MS patients being seen remotely

Neurology – Journal Spy

Journal Spy, Multiple Sclerosis Room

The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary?

May 13, 2020

How is COVID-19 affecting MS patients?

Neurological conditions, Neurology, Multiple Sclerosis Room

How is COVID-19 affecting MS patients?

May 06, 2020

Neurology – Journal Spy

Journal Spy, Multiple Sclerosis Room

Impaired connectivity within neuromodulatory networks in multiple sclerosis and clinical implications.

Mar 29, 2020

Neurology – Journal Spy

Journal Spy, Multiple Sclerosis Room

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.

Mar 22, 2020

Webinar summary: ‘Managing MS remotely during the COVID-19 pandemic’

Neurology, Multiple Sclerosis Room

Webinar summary: ‘Managing MS remotely during the COVID-19 pandemic’

Neurology Academy

Mar 21, 2020

Webinar with Prof Gavin Giovannoni: Managing MS remotely during the COVID-19 pandemic

Neurology, Multiple Sclerosis Room

Webinar with Prof Gavin Giovannoni: Managing MS remotely during the COVID-19 pandemic

Neurology Academy

Mar 19, 2020

Neurology – Journal Spy

Journal Spy, Multiple Sclerosis Room

Cerebellar gray matter lesions are common in pediatric multiple sclerosis at clinical onset.

Mar 07, 2020

Neurology – Journal Spy

Journal Spy, Multiple Sclerosis Room

Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study.

Mar 06, 2020